Literature DB >> 25828886

The specific relationship between vitamin D deficiency and diabetic nephropathy among patients with advanced chronic kidney disease: a cross-sectional study in Gran Canaria, Spain.

Rosa M Sánchez-Hernández1, César García-Cantón, Dionisio L Lorenzo, Virginia Quevedo, Elvira Bosch, Laura López-Ríos, Marta Riaño, Mauro Boronat.   

Abstract

AIMS: Vitamin D deficiency is highly prevalent in subjects with advanced chronic kidney disease (CKD), but diabetes, the most common cause of CKD, has also been linked to low levels of serum 25-hydroxyvitamin D [25(OH)D]. We compare vitamin D status between subjects with type 2 diabetes-related advanced CKD and subjects with either advanced CKD without diabetes or type 2 diabetes without advanced CKD.
METHODS: Subjects were patients with advanced CKD (estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2) from February 2011 to November 2013 (113 with diabetes-related CKD and 80 without diabetes) and 61 patients with long-lasting type 2 diabetes without advanced CKD, simultaneously enrolled from our center. Participants fulfilled a survey questionnaire and underwent physical examination, blood samples, and 24-h urine collection. Kidney disease was assessed using eGFR and 24-h urinary protein excretion. Serum 25(OH)D was measured by chemiluminescence immunoassay.
RESULTS: The prevalence of vitamin D deficiency (25(OH)D < 20 ng/mL) was 70.8% in subjects with diabetes-related CKD, 38.8% in subjects with non-diabetic CKD and 41% in subjects with diabetes without advanced CKD. Adjusted means (95% confidence interval (CI)) of 25(OH)D in participants with diabetes-related CKD, in nondiabetic participants with CKD, and in participants with diabetes without advanced CKD were, respectively, 17.5 (14.2 - 20.7), 23.6 (19.4 - 27.8), and 23.5 (16.8 - 30.3) ng/mL (p = 0.023).
CONCLUSIONS: Low vitamin D status is characteristically associated with advanced diabetic nephropathy. This relationship is not entirely attributable to the individual effects of CKD or long-lasting diabetes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25828886     DOI: 10.5414/cn108446

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease.

Authors:  Mei Lin; Ping Gao; Tianya Zhao; Lei He; Mengshi Li; Yaoyao Li; Hua Shui; Xiaoyan Wu
Journal:  Mol Biol Rep       Date:  2016-03-12       Impact factor: 2.316

2.  Lower serum 25-hydroxyvitamin D levels are associated with impaired glomerular filtration rate in type 2 diabetes patients.

Authors:  Angélica Dall'Agnol; Letícia de Almeida Brondani; Vítor da Agostim Cancelier; Eduardo Guimarães Camargo; Sandra Pinho Silveiro
Journal:  Ther Adv Endocrinol Metab       Date:  2020-07-27       Impact factor: 3.565

3.  The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus.

Authors:  Celil Alper Usluogullari; Fevzi Balkan; Sedat Caner; Rifki Ucler; Cafer Kaya; Reyhan Ersoy; Bekir Cakir
Journal:  BMC Endocr Disord       Date:  2015-06-25       Impact factor: 2.763

4.  Attenuation of Oxidative Stress, Interleukin-6, High-Sensitivity C-Reactive Protein, Plasminogen Activator Inhibitor-1, and Fibrinogen with Oral Vitamin D Supplementation in Patients with T2DM having Vitamin D Deficiency.

Authors:  Pullaiah Pasupuleti; M M Suchitra; Aparna R Bitla; Alok Sachan
Journal:  J Lab Physicians       Date:  2021-12-31

Review 5.  The Role of Vitamin D in Diabetes and Cardiovascular Disease: An Updated Review of the Literature.

Authors:  Dimitrios Papandreou; Zujaja-Tul-Noor Hamid
Journal:  Dis Markers       Date:  2015-10-20       Impact factor: 3.434

Review 6.  The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach.

Authors:  Charlotte Delrue; Reinhart Speeckaert; Joris R Delanghe; Marijn M Speeckaert
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

7.  Vitamin D supplementation in the treatment of type 2 diabetic microangiopathy: A protocol for a systematic review and meta-analysis.

Authors:  Junmin Chen; Xiayu Gong; Jie Liu; Tingting Wang; Xiaoyan Shi; Xiaoran Zhang; Qiu Chen
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.